European Association of E-Pharmacies (EAEP): EAEP as a Driving Force and Think Tank: European Association of Online Pharmacies Repositions Itself
(Brussels/Berlin): – The leading association of European online pharmacies has a new board team, a new name and a new external image:
Walter Hess, Head Germany in the Group Management of the Zur Rose Group and CEO of DocMorris N.V., is now president of the association and Stefan Feltens, CEO SHOP APOTHEKE EUROPE, is vice president and secretary general. With the new leadership duo, the association of online pharmacies will shape the European healthcare sector’s digital transformation in a future-oriented way. A key goal is to further expand the practical patient benefits of online pharmacies in the implementation of future e-health concepts. Vladimir Finsterle, CEO and founder of Pearls Health Cyber s.r.o., and Gianni De Gaspari, CEO and co-founder of the online pharmacy Viata, complete the board.
By changing its name from EAMSP (European Association of Mail Service Pharmacies) to EAEP (European Association of E-Pharmacies), the association underlines its key role in Europe’s increasingly digitised healthcare systems. As online pharmacies, the EAEP’s long-standing members ensure that people all over Europe have optimal access to medicines and pharmaceutical advice every single day. Accordingly, the new logo symbolises the connection between people and pharmacies.
"With Walter Hess, the EAEP gains an experienced market expert as president," says Stefan Feltens. "Together we will demonstrate that the members of the EAEP have systemically relevant answers to changing customer needs and market conditions. To ensure this, we will continue and further intensify our dialogue with politics, society and the economy. We see ourselves as a driving force and use our digital skills for the benefit of consumers.
"As a leadership duo, we want to help shape the future of the healthcare system. We see the EAEP as a European think tank for e-health issues. As pioneers in the European pharmacy market, we will leverage digital solutions to contribute to advancing access, safety, quality, service and sustainability in healthcare in the interest of consumers across Europe," emphasises Walter Hess.
The new website www.eaep.com gives the association a contemporary web presence that describes its services and positions and provides a wide range of information on the European health market, from statements on legislation to electronic prescriptions.
Profile: The European Association of E-Pharmacies (EAEP) represents the interests of its members and protects the needs of its members' patients and customers. It informs the public in a transparent manner, enters into a dialogue with politics, the economy and market partners, and contributes its concepts to strengthen the European health sector and to enable cost reductions through digitisation.
The members of the EAEP are pioneers in digital solutions designed to continuously improve the quality, safety and efficiency of healthcare for people across Europe. The association bundles the voices of its members in position papers and promotes interaction and knowledge exchange.
Avenue Marnix 28
B-1000 Ixelles / Brussels
About news aktuell GmbH
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
BMW Group: “BMW Esports Boost 2021”: a new event for the esports sector live from BMW Welt.19.4.2021 13:56:45 CEST | Press release
• “BMW Esports Boost” brings together an international who's who of the esports world. • The premiere of this globally unique format live from BMW Welt is on June 28, 2021. • BMW is in partnership with Seven.One Sports. • Gain fresh inspiration and exclusive insights from top industry experts such as Jens Hilgers, Ralf Reichert, Christopher Hana, Brandon Snow and Tobias Knoke. • Exciting panel discussions and best practices are aimed at anyone who wants to invest in this market and help shape the future of esports. • Tickets are available now at bmwesportsboost.com. (Munich, Germany): Esports has long since developed from a niche sport into a global trend and an important economic factor. Through its commitment to esports, BMW is one of the driving forces in this fast-growing segment and wants to set new standards in storytelling and innovation. As the sports arm of the Seven.One Entertainment Group, Seven.One Sports has been actively promoting the broadcasting and reporting of all asp
CIIE: 200 Days to the 4th China International Import Expo (CIIE)19.4.2021 08:00:00 CEST | Pressemelding
Preparations are in full swing for the fourth China International Import Expo (CIIE), the world’s largest import expo, which is just 200 days away from April 18. Thousands of exhibitors and hundreds of thousands of buyers from across the globe have descended on Shanghai in the past three years to reap the benefits offered by the expo. With its growing exhibition space and influence, the CIIE is becoming a must-attend event for international businesses every November. Here's why you cannot afford to miss out on the truly unique opportunities provided by the CIIE. Firstly, it’s large in scale and covers extensive industries. The CIIE has grown in scale and influence each year. In 2020, the expo covered 360,000 square meters -- equivalent to the size of almost 70 standard football fields. The global trade fair caters to a complete range of industries, including food and agricultural products, automobiles, intelligent and information technology, consumer goods, medical devices, healthcare
ARD Presse: CIVIS MEDIA PRIZE 2021 - 23 productions nominated, 5 podcasts for the public vote15.4.2021 11:22:26 CEST | Press release
(Cologne, Germany): CIVIS Media Prize 2021 – The 23 nominees of what is Europe's most important media prize when it comes to integration and cultural diversity have been selected: Candidates for the CIVIS Media Prize include entries from ARTE, Bayerischer Rundfunk, Filmakademie Baden-Württemberg, FYEO, HBO, Mitteldeutscher Rundfunk, Norddeutscher Rundfunk, Österreichischer Rundfunk, ProSieben, Radio Bremen, Saarländischer Rundfunk, Schweizer Radio und Fernsehen, Südwestrundfunk, Westdeutscher Rundfunk and ZDF. The productions deal with highly topical issues such as flight, racism, right-wing extremism and antisemitism in many different ways; however, they also cover strategies against hate and violence as well as strategies for the peaceful coexistence of people with diverse geographical and cultural origins. Nearly 800 productions from television, radio and the Internet were submitted for the CIVIS Competition 2021. They came from 20 EU states and Switzerland. The complete list of nom
Grünenthal Group: Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee12.4.2021 11:47:13 CEST | Press release
With the acquisition of Mestex AG, Grünenthal secures global rights for an attractive late-stage asset that could offer an innovative therapy option for millions of patients affected by pain related to osteoarthritis of the knee. MTX-071 (resiniferatoxin) is a highly potent Transient Receptor Potential Vanilloid 1 (TRPV1) agonist. Its administration can reversibly defunctionalise TRPV1-expressing nociceptors. This can result in long lasting pain relief. (Aachen, Germany) –Today, Grünenthal has announced the acquisition of Mestex AG through the takeover of all of its shares and options. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee. The investigational medicine is currently concluding Phase II of clinical development and is about to enter Phase III. Initial data showed a long-lasting and significant analgesic effect and function
Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry12.4.2021 09:00:00 CEST | Press release
IRVINE, CA., April 12, 2021 – Fluxergy, Inc., a medical diagnostic testing platform company with a detection technology solution capable of multimodality, announced today that it has obtained CE marking for its one-hour COVID-19 RT-PCR test, to use by healthcare professionals as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2. The CE-mark will allow Fluxergy’s innovative testing platform to enter the European Union market and any other markets that accept CE-marking as valid regulatory approval. Fluxergy’s platform is an automated, sample-to-answer testing platform with multimodal capability allowing for a variety of assay types, such as molecular, immunochemistry, chemistry, and cytometry assays, to be run simultaneously on the same cartridge. This will give users the ability to run unique Point-of-Care (PoC) panels with the potential ability to do built-in reflex testing, among other capabilities. Potential environments for rapid testing applications include emergency ro
Avonisys AG: Avonisys AG wins patent litigation case against Synova SA7.4.2021 15:36:04 CEST | Press release
Swiss Federal Patent Court rules in favour of Avonisys AG in all relevant aspects and convicts Synova SA under the unfair competition act:
Grunenthal Group: Grünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks7.4.2021 11:39:12 CEST | Press release
• Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry • Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies like Pfizer and Roche (Aachen, Germany): Grünenthal, a global science-based pharmaceutical company, today announced that Sustainalytics, a Morningstar company and a globally-recognized provider of ESG research, ratings and data, has assessed it as having overall medium ESG risk. In addition, Sustainalytics acknowledged that Grünenthal has a strong management of its ESG risks. This places Grünenthal in the top five percent of the global pharmaceuticals subsector. “The long-term success of companies can no longer be measured by financial success alone. As a science-based company, Grünenthal strives to make a net-positive impact on the society,” said Gabriel Baertschi, CEO Grünenthal. “While we are proud to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom